Oncology Venture A/S ("Oncology Venture", formerly Medical Prognosis Institute A/S) hereby publishes the financial ...
Medibio will leverage its proprietary Digital Mental Health platform to process Otsuka clinical data ...
CA-327, a PD-L1/TIM3 dual antagonist designed and optimized by Aurigene, licensed as the 2nd ...
